💼 The collaboration will focus on the development and manufacturing of cell therapies using Multiply Labs’ novel encapsulation technology.
🔬 Thermo Fisher will provide its expertise in cell therapy manufacturing and scale-up capabilities.
👥 The partnership aims to accelerate the development and commercialization of new cell therapies for patients.
🏭 This collaboration highlights the importance of partnerships in advancing the field of cell therapy.
Introduction:
The article discusses the partnership between Multiply Labs and Thermo Fisher, which aims to expand the development of cell therapy. Multiply Labs is a pharmaceutical company that focuses on personalized medicine, while Thermo Fisher is a leading provider of scientific research services and products. This partnership will allow Multiply Labs to leverage Thermo Fisher’s expertise and resources to advance their cell therapy platform.
- Multiply Labs and Thermo Fisher have entered into a partnership to expand the development of cell therapy.
- Multiply Labs specializes in personalized medicine and has developed a cell therapy platform that can be customized for individual patients.
- Thermo Fisher will provide resources and expertise to help Multiply Labs scale up their cell therapy platform and bring it to market.
- The partnership will enable Multiply Labs to benefit from Thermo Fisher’s global presence and established infrastructure in the biotechnology industry.
- This collaboration has the potential to accelerate the development and commercialization of personalized cell therapies.
Conclusion:
The partnership between Multiply Labs and Thermo Fisher is a significant step towards advancing the development of cell therapy. This collaboration will allow Multiply Labs to leverage Thermo Fisher’s resources and expertise, which could expedite the commercialization of their personalized cell therapy platform. With Thermo Fisher’s global presence and established infrastructure, Multiply Labs will be well-positioned to bring their innovative cell therapies to market and potentially revolutionize the field of personalized medicine.
